AI is accelerating our ability to discover new compounds. Our understanding of what those compounds actually do in the brain needs to keep pace.

At Ex Silico, we have developed a platform to discover and experimentally evaluate brain-active compounds in under 24 hours. We combine chemical, circuit, and behavioral characterization to develop drugs designed to enhance human cognition.

We hyperscale human cognition.